Previously, industry-sponsored researchers showed that alendronate remained safe and effective throughout 7 years of therapy (Journal Watch Oct 20 2000). Now the same group reports 10-year follow ...
The participants newly initiated either denosumab or a different oral bisphosphonate, including alendronate, ibandronate, risedronate, or zoledronic acid, between 2012 and 2018. The researchers used ...